Investigation Overview
San Diego, Jan. 26, 2012 (Shareholders Foundation) -- The announcement by Amgen that it intends to will acquire Micromet for $11 per share prompted an investigation for investors in Micromet Inc. (NASDAQ:MITI) shares concerning whether the offer to acquire Micromet and the buyout process are unfair to investors in NASDAQ:MITI shares. The investigations by law firms concern whether Mi...
You must register (for free) or login to view the entire investigation.